InvestorsHub Logo
Followers 33
Posts 5288
Boards Moderated 0
Alias Born 01/23/2019

Re: Bill B post# 301964

Tuesday, 09/29/2020 11:44:30 AM

Tuesday, September 29, 2020 11:44:30 AM

Post# of 426185
BillB, If I understand the idea of amarin going with an authentic generic is that they would utilize the exact same EPA but market it as a generic, lower the price so insurance companies would place vascepa in a lower tier as a generic thus increasing the volume of scripts. Margins wouldn't be as great but the volume of sales would actually increase revenues.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News